Skinvisible, Inc. financial data

Symbol
SKVI on OTC
Location
6320 S Sandhill Road, Unit 9, Las Vegas, NV
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.82 % -21.1%
Debt-to-equity -102 % +0.3%
Return On Equity 12.9 % -63.5%
Return On Assets -352 % +50.7%
Operating Margin -3K % -16.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.4M shares +10.5%
Common Stock, Shares, Outstanding 5.4M shares +10.5%
Entity Public Float 3.52M USD +781%
Common Stock, Value, Issued 5.4K USD +10.5%
Weighted Average Number of Shares Outstanding, Basic 5.4M shares +19%
Weighted Average Number of Shares Outstanding, Diluted 5.06M shares +11.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 20K USD 0%
Operating Income (Loss) -600K USD -16.3%
Net Income (Loss) Attributable to Parent -527K USD +55.5%
Earnings Per Share, Diluted 0 USD/shares +78.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 5K USD 0%
Assets, Current 33.1K USD -7.75%
Assets 143K USD -12.1%
Liabilities, Current 4.53M USD +12.5%
Liabilities 9.9M USD +1.57%
Retained Earnings (Accumulated Deficit) -40.5M USD -1.32%
Stockholders' Equity Attributable to Parent -9.75M USD -1.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -9.75M USD -1.8%
Liabilities and Equity 143K USD -12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.7K USD -158%
Net Cash Provided by (Used in) Financing Activities 34.8K USD +78.4%
Net Cash Provided by (Used in) Investing Activities -525 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 5.4M shares +10.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.06K USD -57.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 120 USD -98.3%
Deferred Tax Assets, Gross 8.4M USD +1.21%
Additional Paid in Capital 30.7M USD +1.17%
Amortization of Intangible Assets 4.7K USD +1.1%
Interest Expense 620K USD -7.22%